Category - AstraZeneca

• AstraZenec­a nerve drug trial disappoint­s
• FTSE 100 held back by AstraZenec­a trial setback
• Attorney General Ken Paxton Secures Nearly $34 Million in Settlement Agreement with Big Pharma Company AstraZenec­a for Giving Illegal Kickbacks to Providers to Prescribe Its Drugs to Texans
• Justices spurn drug firms’ appeal of cost negotiatio­n program
• Justices spurn drug firms’ appeal of cost negotiatio­n program
• Justices reject pharma’s push to block drug price cuts
• AstraZenec­a makes surprise U-turn with £300m pharma investment in UK
• AstraZenec­a to invest $405 million in Britain
• AstraZenec­a will invest $405 million in Britain
• AstraZenec­a to invest $405 million in Britain
• AstraZenec­a to invest $405 million in Britain
• AstraZenec­a to acquire Modella AI to speed drug research
• AstraZenec­a to acquire Modella AI to speed drug research
• AstraZenec­a lauds nation for rare disease control
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• In July, AstraZenec­a announced a sprawling $50 billion investment plan for the U.S. market and in late September said it would do a full U.S. listing of its shares alongside its current London listing.
• Drugmaker AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a unveils expanded Coppell facility
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals medicine deal that will lower drug prices in U.S.
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals American medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a seals U.S. medicine deal
• AstraZenec­a to lower drug prices for Medicaid under deal with Trump
• AstraZenec­a to lower drug prices for Medicaid under deal with Trump
• AstraZenec­a to lower Medicaid prices
• AstraZenec­a to lower Medicaid prices
• Drugmaker agrees to cut costs for Medicaid
• AstraZenec­a makes deal with Trump to lower drug prices and avoid tariffs
• AstraZenec­a to upgrade US listing in ‘knock-back for London’